HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies.

Abstract
Insulin-like growth factors (IGFs) and insulin-like growth factor binding proteins (IGFBPs) have been implicated in the aetiology of several cancers. To better understand whether anthropometric, behavioural and sociodemographic factors may play a role in cancer risk via IGF signalling, we examined the cross-sectional associations of these exposures with circulating concentrations of IGFs (IGF-I and IGF-II) and IGFBPs (IGFBP-1, IGFBP-2 and IGFBP-3). The Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group dataset includes individual participant data from 16,024 male controls (i.e. without prostate cancer) aged 22-89 years from 22 prospective studies. Geometric means of protein concentrations were estimated using analysis of variance, adjusted for relevant covariates. Older age was associated with higher concentrations of IGFBP-1 and IGFBP-2 and lower concentrations of IGF-I, IGF-II and IGFBP-3. Higher body mass index was associated with lower concentrations of IGFBP-1 and IGFBP-2. Taller height was associated with higher concentrations of IGF-I and IGFBP-3 and lower concentrations of IGFBP-1. Smokers had higher concentrations of IGFBP-1 and IGFBP-2 and lower concentrations of IGFBP-3 than nonsmokers. Higher alcohol consumption was associated with higher concentrations of IGF-II and lower concentrations of IGF-I and IGFBP-2. African Americans had lower concentrations of IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 and Hispanics had lower IGF-I, IGF-II and IGFBP-3 than non-Hispanic whites. These findings indicate that a range of anthropometric, behavioural and sociodemographic factors are associated with circulating concentrations of IGFs and IGFBPs in men, which will lead to a greater understanding of the mechanisms through which these factors influence cancer risk.
AuthorsEleanor L Watts, Aurora Perez-Cornago, Paul N Appleby, Demetrius Albanes, Eva Ardanaz, Amanda Black, H Bas Bueno-de-Mesquita, June M Chan, Chu Chen, S A Paul Chubb, Michael B Cook, Mélanie Deschasaux, Jenny L Donovan, Dallas R English, Leon Flicker, Neal D Freedman, Pilar Galan, Graham G Giles, Edward L Giovannucci, Marc J Gunter, Laurel A Habel, Christel Häggström, Christopher Haiman, Freddie C Hamdy, Serge Hercberg, Jeff M Holly, Jiaqi Huang, Wen-Yi Huang, Mattias Johansson, Rudolf Kaaks, Tatsuhiko Kubo, J Athene Lane, Tracy M Layne, Loic Le Marchand, Richard M Martin, E Jeffrey Metter, Kazuya Mikami, Roger L Milne, Howard A Morris, Lorelei A Mucci, David E Neal, Marian L Neuhouser, Steven E Oliver, Kim Overvad, Kotaro Ozasa, Valeria Pala, Claire H Pernar, Michael Pollak, Mari-Anne Rowlands, Catherine A Schaefer, Jeannette M Schenk, Pär Stattin, Akiko Tamakoshi, Elin Thysell, Mathilde Touvier, Antonia Trichopoulou, Konstantinos K Tsilidis, Stephen K Van Den Eeden, Stephanie J Weinstein, Lynne Wilkens, Bu B Yeap, Timothy J Key, Naomi E Allen, Ruth C Travis
JournalInternational journal of cancer (Int J Cancer) Vol. 145 Issue 12 Pg. 3244-3256 (12 15 2019) ISSN: 1097-0215 [Electronic] United States
PMID30873591 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2019 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Chemical References
  • Biomarkers, Tumor
  • Insulin-Like Growth Factor Binding Proteins
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Anthropometry (methods)
  • Biomarkers, Tumor (blood, metabolism)
  • Cross-Sectional Studies
  • Humans
  • Insulin-Like Growth Factor Binding Proteins (blood)
  • Insulin-Like Growth Factor I (metabolism)
  • Insulin-Like Growth Factor II (metabolism)
  • Male
  • Middle Aged
  • Neoplasms (blood, etiology, metabolism)
  • Prospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: